ERCC1 and neoplasm: The results indicated the average tumor volume of the combined XPF–ERCC1 blocker and 5-FU group was less than the OXA-only group in HCT116 (412 mm3; 593 mm3) or SW620 (1114 mm3; 2218 mm3) cells.